US Patent No. 8,927,515

Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA
Jan 12, 2015

Dicerna Pharmaceuticals has been awarded US Patent No. 8,927,515, "Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA."

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.

Jul
19
Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.